Tag: response

An independent, research-informed evaluation of the Her Bodhi botanical formula — examining its ingredient benefits, weight loss positioning, menopause wellness support, disclosed side effects, and publicly available consumer feedback.

•Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including as a complementary therapy alongside GLP-1 receptor agonists to enhance metabolic health outcomes 
• Clinical data presented at ADA from COVALENT-112 show improvements in HbA1c and C-peptide in type 1 diabetes patients treated with icovamenib, with no evidence of immune activation, and inflammatory markers stable or reduced
• Additionally, the Company expanded its Phase I BMF-650 study to evaluate a rapid one-step titration and enhanced weight loss potential with its oral GLP-1 receptor agonist

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) resulting from allegations that Disc Medicine may have issued materially misleading business information to the investing public.

New end-to-end compliance initiative supports providers preparing for the Federal Government’s expanded NDIS registration reforms ahead of the July 2027 Mandatory Registration deadline

MEXICO CITY, June 05, 2026 (GLOBE NEWSWIRE) -- In the context of World Environment Day, Grupo Bimbo, the largest baking company in the world, reported that by the end of 2025 it has more than 500,000 hectares under regenerative agriculture practices, representing an increase of nearly 73% compared to the more than 290,000 hectares reported at the end of 2024. This progress strengthens the company’s work at the origin of its value chain and reflects its belief that its purpose of nourishing a better world begins with soil health.